RECURRENT PROSTATE CARCINOMA
Clinical trials for RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heat boosts radiation against returning prostate cancer in early trial
Disease control CompletedThis early study tested whether adding heat therapy (hyperthermia) to high-dose radiation is safe for men whose prostate cancer returned after previous radiation. Only 3 men took part, and the main goal was to see side effects. The approach aims to make cancer cells more sensitiv…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
Old worming drug shows promise against tough prostate cancer
Disease control CompletedThis early-stage trial tested a combination of two drugs—enzalutamide, a standard hormone therapy, and niclosamide, a drug usually used for tapeworm infections—in 6 men with castration-resistant prostate cancer that had spread or returned. The goal was to find the safest dose and…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New radiation approach aims to tame multiple tumors at once
Symptom relief CompletedThis early-stage study tested a precise, high-dose radiation technique called SBRT in 42 adults with breast, lung, or prostate cancer that had spread to several places in the body. The main goal was to find the safest dose and check for side effects. Researchers hope this approac…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC